Profil
Helle Størum worked as a Principal at H.
Lundbeck A from 2007 to 2016.
She then worked as a Director of Business Development at Zealand Pharma A from 2016 to 2017, and at Pharmacosmos A from 2017 to 2020.
She also worked as a Principal at Takeda A. Currently, she is the Head of Business Development at Amniotics AB since 2020.
Ms. Størum holds a Master's degree in Business Administration from the University of Southern Denmark.
Ehemalige bekannte Positionen von Helle Størum
| Unternehmen | Position | Ende |
|---|---|---|
| AMNIOTICS AB | Corporate Officer/Principal | 01.12.2023 |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Corporate Officer/Principal | 01.01.2020 |
| ZEALAND PHARMA A/S | Direktor/Vorstandsmitglied | 19.04.2016 |
| H. LUNDBECK A/S | Corporate Officer/Principal | 01.03.2016 |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Corporate Officer/Principal | - |
Ausbildung von Helle Størum
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 6 |
|---|---|
H. Lundbeck A/S
H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
Takeda A/S
Takeda A/S Financial ConglomeratesFinance Engages in holding or owning securities of companies | Finance |
University of Southern Denmark
University of Southern Denmark Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pharmacosmos A/S
Pharmacosmos A/S BiotechnologyHealth Technology Engages in development of treatments for patients suffering from iron deficiency and anemia | Health Technology |
Amniotics AB
Amniotics AB BiotechnologyHealth Technology Develops stem cell-based therapeutics for the treatment of human diseases | Health Technology |
















